Search CommunityWalk:


Therataxis, LLC

1101 E. 33rd Street, Suite B305
Baltimore, MD, USA

Category: Diagnostic/Imaging

Used in the following map:

Maryland Biotech Industry Map

Therataxis, LLC is a biomedical company focused on the development and optimization of new delivery devices through simulation of tissue physiology. It was founded in 2004 by Raghu Raghavan and Martin Brady, with a mission to improve direct delivery of therapeutics into brain and other solid tissue by predicting the distribution of therapies (both particulate and energetic) for specific individuals.

Therataxis' research and development is focused on planning, executing, and monitoring the targeted delivery of therapies into the brain. Its core technologies center on the modeling and simulation of brain response to therapy. The company is focused on predicting the distribution of agents delivered directly into tissue and to develop simulation-based delivery-device designs. It has developed fast stochastic simulation algorithms for transport in a strongly anisotropic, inhomogenous medium, implemented in a comprehensive C++ library designed for efficient prototyping of different mathematical models. The company designs and evaluates devices for direct delivery of therapies to the brain. It is also focused on the development of new methods of using MRI and CT to measure, infer, and estimate three-dimensional maps of important physiological parameters.

Therataxis' modeling, simulation and support technologies include: brain cancer treatments, Parkinson's disease treatments, systemic drug delivery, brain edema, acoustic focusing, catheter device development and testing. It develops computational models, image analysis methods, and device designs to support the direct delivery of therapies into brain tissue. The company has focused its research expertise in physiological modeling, simulation, and medical image processing. It services include: evaluation of packaging of existing devices, designing and construction of prototypes of new devices, quantitative analysis of imaging results, quantitative assessment of indvidual's physiology from radiological imaging, quantitative tracking of surrogate tracers, etc.